Loading…
Clinical characteristics of a case of multiple mitochondrial dysfunction syndrome 3
Objective To further comprehend the phenotype of multiple mitochondrial dysfunction syndrome type 3 (MMDS3:OMIM#615330) caused by IBA57 mutation. We present a case involving a patient who experienced acute neurological regression, and the literature was reviewed. Methods Clinical data and laboratory...
Saved in:
Published in: | Molecular genetics & genomic medicine 2024-06, Vol.12 (6), p.e2485-n/a |
---|---|
Main Authors: | , , , , , , , |
Format: | Article |
Language: | English |
Subjects: | |
Citations: | Items that this one cites |
Online Access: | Get full text |
Tags: |
Add Tag
No Tags, Be the first to tag this record!
|
cited_by | |
---|---|
cites | cdi_FETCH-LOGICAL-c4675-663129f8f5706d3d2b4fb6055a68f6ed44ec8562eb4317ecafcf232a97712db13 |
container_end_page | n/a |
container_issue | 6 |
container_start_page | e2485 |
container_title | Molecular genetics & genomic medicine |
container_volume | 12 |
creator | Xu, Hai Ma, Kai Gao, Yuye Song, Qijun Chen, Chaojin Xu, Xiao Peng, Jiaxi Sun, Yan |
description | Objective
To further comprehend the phenotype of multiple mitochondrial dysfunction syndrome type 3 (MMDS3:OMIM#615330) caused by IBA57 mutation. We present a case involving a patient who experienced acute neurological regression, and the literature was reviewed.
Methods
Clinical data and laboratory test results were collected; early language and development progress were tested; and genetic testing was performed. Bioinformatics analysis was performed using Mutation Taster and PolyPhen‐2, and the literature in databases such as PubMed and CNKI was searched using MMDS3 and IBA57 as keywords.
Results
The child, aged 1 year and 2 months, had motor decline, unable to sit alone, limited right arm movement, hypotonia, hyperreflexia of both knees, and Babinski sign positivity on the right side, accompanied by nystagmus. Blood lactate levels were elevated at 2.50 mmol/L. Brain MR indicated slight swelling in the bilateral frontoparietal and occipital white matter areas and the corpus callosum, with extensive abnormal signals on T1 and T2 images, along with the semioval center and occipital lobes bilaterally. The multiple abnormal signals in the brain suggested metabolic leukoencephalopathy. Whole‐exome sequencing analysis revealed that the child had two heterozygous mutations in the IBA57 gene, c.286T>C (p.Y96H) (likely pathogenic, LP) and c.992T>A (p.L331Q) (variant of uncertain significance, VUS). As of March 2023, a literature search showed that 56 cases of MMDS3 caused by IBA57 mutation had been reported worldwide, with 35 cases reported in China. Among the 35 IBA57 mutations listed in the HGMD database, there were 28 missense or nonsense mutations, 2 splicing mutations, 2 small deletions, and 3 small insertions.
Conclusion
MMDS3 predominantly manifests in infancy, with primary symptoms including feeding difficulties, neurological functional regression, muscle weakness, with severe cases potentially leading to mortality. Diagnosis is supported by elevated lactate levels, multisystem impairment (including auditory and visual systems), and distinctive MRI findings. Whole‐exome sequencing is crucial for diagnosis. Currently, cocktail therapy offers symptomatic relief. |
doi_str_mv | 10.1002/mgg3.2485 |
format | article |
fullrecord | <record><control><sourceid>proquest_doaj_</sourceid><recordid>TN_cdi_doaj_primary_oai_doaj_org_article_b892e55650e34d7c9b19cd8e6df3f216</recordid><sourceformat>XML</sourceformat><sourcesystem>PC</sourcesystem><doaj_id>oai_doaj_org_article_b892e55650e34d7c9b19cd8e6df3f216</doaj_id><sourcerecordid>3072798396</sourcerecordid><originalsourceid>FETCH-LOGICAL-c4675-663129f8f5706d3d2b4fb6055a68f6ed44ec8562eb4317ecafcf232a97712db13</originalsourceid><addsrcrecordid>eNp1kc1u3CAUha2oVRIlWfQFKkvdtItJDJi_VVWNmkmkRF20XSMMlxlG2EzBTjVvX5xJo6RS2XB1OXzcw6mqd6i5RE2Dr_r1mlziVtCj6hQT3C4kZvLNi_qkush525QlRIsYP65OiJCYEIxPq-_L4AdvdKjNRidtRkg-j97kOrpa10ZnmKt-CqPfBah7P0aziYNNvtyx--ymwYw-DnXel2bsoSbn1VunQ4aLp_2s-nn99cfyZnH3bXW7_HK3MC3jdMEYQVg64ShvmCUWd63rWEOpZsIxsG0LRlCGoWsJ4mC0M66Y0pJzhG2HyFl1e-DaqLdql3yv015F7dVjI6a10ql4CaC6YhgoZbQB0lpuZIeksQKYdcRhxArr84G1m7oerIFhTDq8gr4-GfxGreODQghJSTAvhI9PhBR_TZBH1ftsIAQ9QJyyIg3HXAoi58c-_CPdxikN5a9mFRGEMjnb-3RQmRRzTuCep0GNmqNXc_Rqjr5o378c_1n5N-giuDoIfvsA-_-T1P1qRR6RfwC5D7gf</addsrcrecordid><sourcetype>Open Website</sourcetype><iscdi>true</iscdi><recordtype>article</recordtype><pqid>3073835691</pqid></control><display><type>article</type><title>Clinical characteristics of a case of multiple mitochondrial dysfunction syndrome 3</title><source>Wiley Online Library Open Access</source><source>Publicly Available Content Database</source><source>PubMed Central</source><creator>Xu, Hai ; Ma, Kai ; Gao, Yuye ; Song, Qijun ; Chen, Chaojin ; Xu, Xiao ; Peng, Jiaxi ; Sun, Yan</creator><creatorcontrib>Xu, Hai ; Ma, Kai ; Gao, Yuye ; Song, Qijun ; Chen, Chaojin ; Xu, Xiao ; Peng, Jiaxi ; Sun, Yan</creatorcontrib><description>Objective
To further comprehend the phenotype of multiple mitochondrial dysfunction syndrome type 3 (MMDS3:OMIM#615330) caused by IBA57 mutation. We present a case involving a patient who experienced acute neurological regression, and the literature was reviewed.
Methods
Clinical data and laboratory test results were collected; early language and development progress were tested; and genetic testing was performed. Bioinformatics analysis was performed using Mutation Taster and PolyPhen‐2, and the literature in databases such as PubMed and CNKI was searched using MMDS3 and IBA57 as keywords.
Results
The child, aged 1 year and 2 months, had motor decline, unable to sit alone, limited right arm movement, hypotonia, hyperreflexia of both knees, and Babinski sign positivity on the right side, accompanied by nystagmus. Blood lactate levels were elevated at 2.50 mmol/L. Brain MR indicated slight swelling in the bilateral frontoparietal and occipital white matter areas and the corpus callosum, with extensive abnormal signals on T1 and T2 images, along with the semioval center and occipital lobes bilaterally. The multiple abnormal signals in the brain suggested metabolic leukoencephalopathy. Whole‐exome sequencing analysis revealed that the child had two heterozygous mutations in the IBA57 gene, c.286T>C (p.Y96H) (likely pathogenic, LP) and c.992T>A (p.L331Q) (variant of uncertain significance, VUS). As of March 2023, a literature search showed that 56 cases of MMDS3 caused by IBA57 mutation had been reported worldwide, with 35 cases reported in China. Among the 35 IBA57 mutations listed in the HGMD database, there were 28 missense or nonsense mutations, 2 splicing mutations, 2 small deletions, and 3 small insertions.
Conclusion
MMDS3 predominantly manifests in infancy, with primary symptoms including feeding difficulties, neurological functional regression, muscle weakness, with severe cases potentially leading to mortality. Diagnosis is supported by elevated lactate levels, multisystem impairment (including auditory and visual systems), and distinctive MRI findings. Whole‐exome sequencing is crucial for diagnosis. Currently, cocktail therapy offers symptomatic relief.</description><identifier>ISSN: 2324-9269</identifier><identifier>EISSN: 2324-9269</identifier><identifier>DOI: 10.1002/mgg3.2485</identifier><identifier>PMID: 38923322</identifier><language>eng</language><publisher>United States: John Wiley & Sons, Inc</publisher><subject>Abdomen ; acute neurologic regression ; Arm ; Bioinformatics ; Blood ; Blood levels ; Brain ; Carrier Proteins ; Corpus callosum ; Diagnosis ; Female ; Genes ; Genetic analysis ; Genetic counseling ; Genetic screening ; Genetic testing ; Humans ; Hypotonia ; IBA57 ; Infant ; Laboratory tests ; Lactic acid ; Language ; Leukoencephalopathy ; Male ; Microfilament Proteins - genetics ; Mitochondrial Diseases ; multiple mitochondrial dysfunction syndrome (MMDS) ; Muscle strength ; Mutation ; Nonsense mutation ; Occipital lobes ; Original ; Phenotype ; Phenotypes ; Proteins ; Sensory integration ; Substantia alba ; Whole genome sequencing</subject><ispartof>Molecular genetics & genomic medicine, 2024-06, Vol.12 (6), p.e2485-n/a</ispartof><rights>2024 The Author(s). published by Wiley Periodicals LLC.</rights><rights>2024 The Author(s). Molecular Genetics & Genomic Medicine published by Wiley Periodicals LLC.</rights><rights>2024. This work is published under http://creativecommons.org/licenses/by-nc-nd/4.0/ (the “License”). Notwithstanding the ProQuest Terms and Conditions, you may use this content in accordance with the terms of the License.</rights><lds50>peer_reviewed</lds50><oa>free_for_read</oa><woscitedreferencessubscribed>false</woscitedreferencessubscribed><cites>FETCH-LOGICAL-c4675-663129f8f5706d3d2b4fb6055a68f6ed44ec8562eb4317ecafcf232a97712db13</cites><orcidid>0009-0005-6013-2122 ; 0000-0003-3993-1358</orcidid></display><links><openurl>$$Topenurl_article</openurl><openurlfulltext>$$Topenurlfull_article</openurlfulltext><thumbnail>$$Tsyndetics_thumb_exl</thumbnail><linktopdf>$$Uhttps://www.proquest.com/docview/3073835691/fulltextPDF?pq-origsite=primo$$EPDF$$P50$$Gproquest$$Hfree_for_read</linktopdf><linktohtml>$$Uhttps://www.proquest.com/docview/3073835691?pq-origsite=primo$$EHTML$$P50$$Gproquest$$Hfree_for_read</linktohtml><link.rule.ids>230,314,727,780,784,885,11560,25751,27922,27923,37010,37011,44588,46050,46474,53789,53791,74896</link.rule.ids><backlink>$$Uhttps://www.ncbi.nlm.nih.gov/pubmed/38923322$$D View this record in MEDLINE/PubMed$$Hfree_for_read</backlink></links><search><creatorcontrib>Xu, Hai</creatorcontrib><creatorcontrib>Ma, Kai</creatorcontrib><creatorcontrib>Gao, Yuye</creatorcontrib><creatorcontrib>Song, Qijun</creatorcontrib><creatorcontrib>Chen, Chaojin</creatorcontrib><creatorcontrib>Xu, Xiao</creatorcontrib><creatorcontrib>Peng, Jiaxi</creatorcontrib><creatorcontrib>Sun, Yan</creatorcontrib><title>Clinical characteristics of a case of multiple mitochondrial dysfunction syndrome 3</title><title>Molecular genetics & genomic medicine</title><addtitle>Mol Genet Genomic Med</addtitle><description>Objective
To further comprehend the phenotype of multiple mitochondrial dysfunction syndrome type 3 (MMDS3:OMIM#615330) caused by IBA57 mutation. We present a case involving a patient who experienced acute neurological regression, and the literature was reviewed.
Methods
Clinical data and laboratory test results were collected; early language and development progress were tested; and genetic testing was performed. Bioinformatics analysis was performed using Mutation Taster and PolyPhen‐2, and the literature in databases such as PubMed and CNKI was searched using MMDS3 and IBA57 as keywords.
Results
The child, aged 1 year and 2 months, had motor decline, unable to sit alone, limited right arm movement, hypotonia, hyperreflexia of both knees, and Babinski sign positivity on the right side, accompanied by nystagmus. Blood lactate levels were elevated at 2.50 mmol/L. Brain MR indicated slight swelling in the bilateral frontoparietal and occipital white matter areas and the corpus callosum, with extensive abnormal signals on T1 and T2 images, along with the semioval center and occipital lobes bilaterally. The multiple abnormal signals in the brain suggested metabolic leukoencephalopathy. Whole‐exome sequencing analysis revealed that the child had two heterozygous mutations in the IBA57 gene, c.286T>C (p.Y96H) (likely pathogenic, LP) and c.992T>A (p.L331Q) (variant of uncertain significance, VUS). As of March 2023, a literature search showed that 56 cases of MMDS3 caused by IBA57 mutation had been reported worldwide, with 35 cases reported in China. Among the 35 IBA57 mutations listed in the HGMD database, there were 28 missense or nonsense mutations, 2 splicing mutations, 2 small deletions, and 3 small insertions.
Conclusion
MMDS3 predominantly manifests in infancy, with primary symptoms including feeding difficulties, neurological functional regression, muscle weakness, with severe cases potentially leading to mortality. Diagnosis is supported by elevated lactate levels, multisystem impairment (including auditory and visual systems), and distinctive MRI findings. Whole‐exome sequencing is crucial for diagnosis. Currently, cocktail therapy offers symptomatic relief.</description><subject>Abdomen</subject><subject>acute neurologic regression</subject><subject>Arm</subject><subject>Bioinformatics</subject><subject>Blood</subject><subject>Blood levels</subject><subject>Brain</subject><subject>Carrier Proteins</subject><subject>Corpus callosum</subject><subject>Diagnosis</subject><subject>Female</subject><subject>Genes</subject><subject>Genetic analysis</subject><subject>Genetic counseling</subject><subject>Genetic screening</subject><subject>Genetic testing</subject><subject>Humans</subject><subject>Hypotonia</subject><subject>IBA57</subject><subject>Infant</subject><subject>Laboratory tests</subject><subject>Lactic acid</subject><subject>Language</subject><subject>Leukoencephalopathy</subject><subject>Male</subject><subject>Microfilament Proteins - genetics</subject><subject>Mitochondrial Diseases</subject><subject>multiple mitochondrial dysfunction syndrome (MMDS)</subject><subject>Muscle strength</subject><subject>Mutation</subject><subject>Nonsense mutation</subject><subject>Occipital lobes</subject><subject>Original</subject><subject>Phenotype</subject><subject>Phenotypes</subject><subject>Proteins</subject><subject>Sensory integration</subject><subject>Substantia alba</subject><subject>Whole genome sequencing</subject><issn>2324-9269</issn><issn>2324-9269</issn><fulltext>true</fulltext><rsrctype>article</rsrctype><creationdate>2024</creationdate><recordtype>article</recordtype><sourceid>24P</sourceid><sourceid>PIMPY</sourceid><sourceid>DOA</sourceid><recordid>eNp1kc1u3CAUha2oVRIlWfQFKkvdtItJDJi_VVWNmkmkRF20XSMMlxlG2EzBTjVvX5xJo6RS2XB1OXzcw6mqd6i5RE2Dr_r1mlziVtCj6hQT3C4kZvLNi_qkush525QlRIsYP65OiJCYEIxPq-_L4AdvdKjNRidtRkg-j97kOrpa10ZnmKt-CqPfBah7P0aziYNNvtyx--ymwYw-DnXel2bsoSbn1VunQ4aLp_2s-nn99cfyZnH3bXW7_HK3MC3jdMEYQVg64ShvmCUWd63rWEOpZsIxsG0LRlCGoWsJ4mC0M66Y0pJzhG2HyFl1e-DaqLdql3yv015F7dVjI6a10ql4CaC6YhgoZbQB0lpuZIeksQKYdcRhxArr84G1m7oerIFhTDq8gr4-GfxGreODQghJSTAvhI9PhBR_TZBH1ftsIAQ9QJyyIg3HXAoi58c-_CPdxikN5a9mFRGEMjnb-3RQmRRzTuCep0GNmqNXc_Rqjr5o378c_1n5N-giuDoIfvsA-_-T1P1qRR6RfwC5D7gf</recordid><startdate>202406</startdate><enddate>202406</enddate><creator>Xu, Hai</creator><creator>Ma, Kai</creator><creator>Gao, Yuye</creator><creator>Song, Qijun</creator><creator>Chen, Chaojin</creator><creator>Xu, Xiao</creator><creator>Peng, Jiaxi</creator><creator>Sun, Yan</creator><general>John Wiley & Sons, Inc</general><general>John Wiley and Sons Inc</general><general>Wiley</general><scope>24P</scope><scope>WIN</scope><scope>CGR</scope><scope>CUY</scope><scope>CVF</scope><scope>ECM</scope><scope>EIF</scope><scope>NPM</scope><scope>AAYXX</scope><scope>CITATION</scope><scope>7QO</scope><scope>8FD</scope><scope>8FE</scope><scope>8FH</scope><scope>ABUWG</scope><scope>AEUYN</scope><scope>AFKRA</scope><scope>AZQEC</scope><scope>BBNVY</scope><scope>BENPR</scope><scope>BHPHI</scope><scope>CCPQU</scope><scope>DWQXO</scope><scope>FR3</scope><scope>GNUQQ</scope><scope>HCIFZ</scope><scope>LK8</scope><scope>M7P</scope><scope>P64</scope><scope>PIMPY</scope><scope>PQEST</scope><scope>PQQKQ</scope><scope>PQUKI</scope><scope>PRINS</scope><scope>RC3</scope><scope>7X8</scope><scope>5PM</scope><scope>DOA</scope><orcidid>https://orcid.org/0009-0005-6013-2122</orcidid><orcidid>https://orcid.org/0000-0003-3993-1358</orcidid></search><sort><creationdate>202406</creationdate><title>Clinical characteristics of a case of multiple mitochondrial dysfunction syndrome 3</title><author>Xu, Hai ; Ma, Kai ; Gao, Yuye ; Song, Qijun ; Chen, Chaojin ; Xu, Xiao ; Peng, Jiaxi ; Sun, Yan</author></sort><facets><frbrtype>5</frbrtype><frbrgroupid>cdi_FETCH-LOGICAL-c4675-663129f8f5706d3d2b4fb6055a68f6ed44ec8562eb4317ecafcf232a97712db13</frbrgroupid><rsrctype>articles</rsrctype><prefilter>articles</prefilter><language>eng</language><creationdate>2024</creationdate><topic>Abdomen</topic><topic>acute neurologic regression</topic><topic>Arm</topic><topic>Bioinformatics</topic><topic>Blood</topic><topic>Blood levels</topic><topic>Brain</topic><topic>Carrier Proteins</topic><topic>Corpus callosum</topic><topic>Diagnosis</topic><topic>Female</topic><topic>Genes</topic><topic>Genetic analysis</topic><topic>Genetic counseling</topic><topic>Genetic screening</topic><topic>Genetic testing</topic><topic>Humans</topic><topic>Hypotonia</topic><topic>IBA57</topic><topic>Infant</topic><topic>Laboratory tests</topic><topic>Lactic acid</topic><topic>Language</topic><topic>Leukoencephalopathy</topic><topic>Male</topic><topic>Microfilament Proteins - genetics</topic><topic>Mitochondrial Diseases</topic><topic>multiple mitochondrial dysfunction syndrome (MMDS)</topic><topic>Muscle strength</topic><topic>Mutation</topic><topic>Nonsense mutation</topic><topic>Occipital lobes</topic><topic>Original</topic><topic>Phenotype</topic><topic>Phenotypes</topic><topic>Proteins</topic><topic>Sensory integration</topic><topic>Substantia alba</topic><topic>Whole genome sequencing</topic><toplevel>peer_reviewed</toplevel><toplevel>online_resources</toplevel><creatorcontrib>Xu, Hai</creatorcontrib><creatorcontrib>Ma, Kai</creatorcontrib><creatorcontrib>Gao, Yuye</creatorcontrib><creatorcontrib>Song, Qijun</creatorcontrib><creatorcontrib>Chen, Chaojin</creatorcontrib><creatorcontrib>Xu, Xiao</creatorcontrib><creatorcontrib>Peng, Jiaxi</creatorcontrib><creatorcontrib>Sun, Yan</creatorcontrib><collection>Wiley Online Library Open Access</collection><collection>Wiley Online Library Free Content</collection><collection>Medline</collection><collection>MEDLINE</collection><collection>MEDLINE (Ovid)</collection><collection>MEDLINE</collection><collection>MEDLINE</collection><collection>PubMed</collection><collection>CrossRef</collection><collection>Biotechnology Research Abstracts</collection><collection>Technology Research Database</collection><collection>ProQuest SciTech Collection</collection><collection>ProQuest Natural Science Collection</collection><collection>ProQuest Central (Alumni)</collection><collection>ProQuest One Sustainability</collection><collection>ProQuest Central</collection><collection>ProQuest Central Essentials</collection><collection>Biological Science Collection</collection><collection>AUTh Library subscriptions: ProQuest Central</collection><collection>ProQuest Natural Science Collection</collection><collection>ProQuest One Community College</collection><collection>ProQuest Central</collection><collection>Engineering Research Database</collection><collection>ProQuest Central Student</collection><collection>SciTech Premium Collection</collection><collection>Biological Sciences</collection><collection>Biological Science Database</collection><collection>Biotechnology and BioEngineering Abstracts</collection><collection>Publicly Available Content Database</collection><collection>ProQuest One Academic Eastern Edition (DO NOT USE)</collection><collection>ProQuest One Academic</collection><collection>ProQuest One Academic UKI Edition</collection><collection>ProQuest Central China</collection><collection>Genetics Abstracts</collection><collection>MEDLINE - Academic</collection><collection>PubMed Central (Full Participant titles)</collection><collection>DOAJ Directory of Open Access Journals</collection><jtitle>Molecular genetics & genomic medicine</jtitle></facets><delivery><delcategory>Remote Search Resource</delcategory><fulltext>fulltext</fulltext></delivery><addata><au>Xu, Hai</au><au>Ma, Kai</au><au>Gao, Yuye</au><au>Song, Qijun</au><au>Chen, Chaojin</au><au>Xu, Xiao</au><au>Peng, Jiaxi</au><au>Sun, Yan</au><format>journal</format><genre>article</genre><ristype>JOUR</ristype><atitle>Clinical characteristics of a case of multiple mitochondrial dysfunction syndrome 3</atitle><jtitle>Molecular genetics & genomic medicine</jtitle><addtitle>Mol Genet Genomic Med</addtitle><date>2024-06</date><risdate>2024</risdate><volume>12</volume><issue>6</issue><spage>e2485</spage><epage>n/a</epage><pages>e2485-n/a</pages><issn>2324-9269</issn><eissn>2324-9269</eissn><abstract>Objective
To further comprehend the phenotype of multiple mitochondrial dysfunction syndrome type 3 (MMDS3:OMIM#615330) caused by IBA57 mutation. We present a case involving a patient who experienced acute neurological regression, and the literature was reviewed.
Methods
Clinical data and laboratory test results were collected; early language and development progress were tested; and genetic testing was performed. Bioinformatics analysis was performed using Mutation Taster and PolyPhen‐2, and the literature in databases such as PubMed and CNKI was searched using MMDS3 and IBA57 as keywords.
Results
The child, aged 1 year and 2 months, had motor decline, unable to sit alone, limited right arm movement, hypotonia, hyperreflexia of both knees, and Babinski sign positivity on the right side, accompanied by nystagmus. Blood lactate levels were elevated at 2.50 mmol/L. Brain MR indicated slight swelling in the bilateral frontoparietal and occipital white matter areas and the corpus callosum, with extensive abnormal signals on T1 and T2 images, along with the semioval center and occipital lobes bilaterally. The multiple abnormal signals in the brain suggested metabolic leukoencephalopathy. Whole‐exome sequencing analysis revealed that the child had two heterozygous mutations in the IBA57 gene, c.286T>C (p.Y96H) (likely pathogenic, LP) and c.992T>A (p.L331Q) (variant of uncertain significance, VUS). As of March 2023, a literature search showed that 56 cases of MMDS3 caused by IBA57 mutation had been reported worldwide, with 35 cases reported in China. Among the 35 IBA57 mutations listed in the HGMD database, there were 28 missense or nonsense mutations, 2 splicing mutations, 2 small deletions, and 3 small insertions.
Conclusion
MMDS3 predominantly manifests in infancy, with primary symptoms including feeding difficulties, neurological functional regression, muscle weakness, with severe cases potentially leading to mortality. Diagnosis is supported by elevated lactate levels, multisystem impairment (including auditory and visual systems), and distinctive MRI findings. Whole‐exome sequencing is crucial for diagnosis. Currently, cocktail therapy offers symptomatic relief.</abstract><cop>United States</cop><pub>John Wiley & Sons, Inc</pub><pmid>38923322</pmid><doi>10.1002/mgg3.2485</doi><tpages>9</tpages><orcidid>https://orcid.org/0009-0005-6013-2122</orcidid><orcidid>https://orcid.org/0000-0003-3993-1358</orcidid><oa>free_for_read</oa></addata></record> |
fulltext | fulltext |
identifier | ISSN: 2324-9269 |
ispartof | Molecular genetics & genomic medicine, 2024-06, Vol.12 (6), p.e2485-n/a |
issn | 2324-9269 2324-9269 |
language | eng |
recordid | cdi_doaj_primary_oai_doaj_org_article_b892e55650e34d7c9b19cd8e6df3f216 |
source | Wiley Online Library Open Access; Publicly Available Content Database; PubMed Central |
subjects | Abdomen acute neurologic regression Arm Bioinformatics Blood Blood levels Brain Carrier Proteins Corpus callosum Diagnosis Female Genes Genetic analysis Genetic counseling Genetic screening Genetic testing Humans Hypotonia IBA57 Infant Laboratory tests Lactic acid Language Leukoencephalopathy Male Microfilament Proteins - genetics Mitochondrial Diseases multiple mitochondrial dysfunction syndrome (MMDS) Muscle strength Mutation Nonsense mutation Occipital lobes Original Phenotype Phenotypes Proteins Sensory integration Substantia alba Whole genome sequencing |
title | Clinical characteristics of a case of multiple mitochondrial dysfunction syndrome 3 |
url | http://sfxeu10.hosted.exlibrisgroup.com/loughborough?ctx_ver=Z39.88-2004&ctx_enc=info:ofi/enc:UTF-8&ctx_tim=2025-01-09T19%3A51%3A12IST&url_ver=Z39.88-2004&url_ctx_fmt=infofi/fmt:kev:mtx:ctx&rfr_id=info:sid/primo.exlibrisgroup.com:primo3-Article-proquest_doaj_&rft_val_fmt=info:ofi/fmt:kev:mtx:journal&rft.genre=article&rft.atitle=Clinical%20characteristics%20of%20a%20case%20of%20multiple%20mitochondrial%20dysfunction%20syndrome%203&rft.jtitle=Molecular%20genetics%20&%20genomic%20medicine&rft.au=Xu,%20Hai&rft.date=2024-06&rft.volume=12&rft.issue=6&rft.spage=e2485&rft.epage=n/a&rft.pages=e2485-n/a&rft.issn=2324-9269&rft.eissn=2324-9269&rft_id=info:doi/10.1002/mgg3.2485&rft_dat=%3Cproquest_doaj_%3E3072798396%3C/proquest_doaj_%3E%3Cgrp_id%3Ecdi_FETCH-LOGICAL-c4675-663129f8f5706d3d2b4fb6055a68f6ed44ec8562eb4317ecafcf232a97712db13%3C/grp_id%3E%3Coa%3E%3C/oa%3E%3Curl%3E%3C/url%3E&rft_id=info:oai/&rft_pqid=3073835691&rft_id=info:pmid/38923322&rfr_iscdi=true |